vs
Side-by-side financial comparison of BRINKS CO (BCO) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
BRINKS CO is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.2× PERRIGO Co plc). BRINKS CO runs the higher net margin — 4.9% vs -127.8%, a 132.7% gap on every dollar of revenue. On growth, BRINKS CO posted the faster year-over-year revenue change (9.1% vs -2.5%). Over the past eight quarters, BRINKS CO's revenue compounded faster (5.6% CAGR vs 1.3%).
The Brink's Company is an American cash handling company, headquartered in Richmond, Virginia. Its operations include cash-in-transit, ATM replenishment & maintenance, and cash management & payment services, such as vault outsourcing, money processing, intelligent safe services, and international transportation of valuables.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
BCO vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.1B |
| Net Profit | $68.1M | $-1.4B |
| Gross Margin | 27.7% | 32.6% |
| Operating Margin | 13.1% | -116.0% |
| Net Margin | 4.9% | -127.8% |
| Revenue YoY | 9.1% | -2.5% |
| Net Profit YoY | 76.9% | -3093.9% |
| EPS (diluted) | $1.62 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $1.1B | ||
| Q3 25 | $1.3B | $1.0B | ||
| Q2 25 | $1.3B | $1.1B | ||
| Q1 25 | $1.2B | $1.0B | ||
| Q4 24 | $1.3B | $1.1B | ||
| Q3 24 | $1.3B | $1.1B | ||
| Q2 24 | $1.3B | $1.1B | ||
| Q1 24 | $1.2B | $1.1B |
| Q4 25 | $68.1M | $-1.4B | ||
| Q3 25 | $36.3M | $7.5M | ||
| Q2 25 | $43.7M | $-8.4M | ||
| Q1 25 | $51.6M | $-6.4M | ||
| Q4 24 | $38.5M | $-44.4M | ||
| Q3 24 | $28.9M | $-21.0M | ||
| Q2 24 | $46.2M | $-108.4M | ||
| Q1 24 | $49.3M | $2.0M |
| Q4 25 | 27.7% | 32.6% | ||
| Q3 25 | 25.8% | 36.1% | ||
| Q2 25 | 24.9% | 34.4% | ||
| Q1 25 | 24.6% | 37.6% | ||
| Q4 24 | 26.1% | 33.9% | ||
| Q3 24 | 25.0% | 37.2% | ||
| Q2 24 | 25.2% | 37.0% | ||
| Q1 24 | 25.0% | 33.1% |
| Q4 25 | 13.1% | -116.0% | ||
| Q3 25 | 11.4% | 7.0% | ||
| Q2 25 | 10.3% | 4.3% | ||
| Q1 25 | 9.6% | 4.5% | ||
| Q4 24 | 8.3% | 10.0% | ||
| Q3 24 | 8.9% | 7.4% | ||
| Q2 24 | 9.3% | -2.5% | ||
| Q1 24 | 9.8% | -5.1% |
| Q4 25 | 4.9% | -127.8% | ||
| Q3 25 | 2.7% | 0.7% | ||
| Q2 25 | 3.4% | -0.8% | ||
| Q1 25 | 4.1% | -0.6% | ||
| Q4 24 | 3.0% | -3.9% | ||
| Q3 24 | 2.3% | -1.9% | ||
| Q2 24 | 3.7% | -10.2% | ||
| Q1 24 | 4.0% | 0.2% |
| Q4 25 | $1.62 | $-10.23 | ||
| Q3 25 | $0.86 | $0.05 | ||
| Q2 25 | $1.03 | $-0.06 | ||
| Q1 25 | $1.18 | $-0.05 | ||
| Q4 24 | $0.87 | $-0.32 | ||
| Q3 24 | $0.65 | $-0.15 | ||
| Q2 24 | $1.02 | $-0.79 | ||
| Q1 24 | $1.09 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | — |
| Total DebtLower is stronger | $4.0B | — |
| Stockholders' EquityBook value | $277.7M | $2.9B |
| Total Assets | $7.3B | $8.5B |
| Debt / EquityLower = less leverage | 14.31× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.3B | $432.1M | ||
| Q2 25 | $1.4B | $454.2M | ||
| Q1 25 | $1.2B | $409.9M | ||
| Q4 24 | $1.4B | $558.8M | ||
| Q3 24 | $1.2B | $1.5B | ||
| Q2 24 | $1.2B | $542.8M | ||
| Q1 24 | $1.1B | $658.5M |
| Q4 25 | $4.0B | — | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $3.9B | — | ||
| Q1 25 | $3.7B | — | ||
| Q4 24 | $3.7B | — | ||
| Q3 24 | $3.7B | — | ||
| Q2 24 | $3.6B | — | ||
| Q1 24 | $3.4B | — |
| Q4 25 | $277.7M | $2.9B | ||
| Q3 25 | $268.5M | $4.4B | ||
| Q2 25 | $254.6M | $4.5B | ||
| Q1 25 | $205.8M | $4.4B | ||
| Q4 24 | $184.9M | $4.3B | ||
| Q3 24 | $277.1M | $4.6B | ||
| Q2 24 | $320.5M | $4.5B | ||
| Q1 24 | $396.4M | $4.7B |
| Q4 25 | $7.3B | $8.5B | ||
| Q3 25 | $7.0B | $10.1B | ||
| Q2 25 | $7.1B | $10.1B | ||
| Q1 25 | $6.6B | $9.8B | ||
| Q4 24 | $6.6B | $9.6B | ||
| Q3 24 | $6.7B | $11.2B | ||
| Q2 24 | $6.6B | $10.4B | ||
| Q1 24 | $6.7B | $10.6B |
| Q4 25 | 14.31× | — | ||
| Q3 25 | 14.05× | — | ||
| Q2 25 | 15.48× | — | ||
| Q1 25 | 18.19× | — | ||
| Q4 24 | 20.26× | — | ||
| Q3 24 | 13.39× | — | ||
| Q2 24 | 11.26× | — | ||
| Q1 24 | 8.67× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | 3.5% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $175.4M | ||
| Q3 25 | $122.1M | $51.7M | ||
| Q2 25 | — | $75.9M | ||
| Q1 25 | $-60.2M | $-64.5M | ||
| Q4 24 | $369.8M | $312.6M | ||
| Q3 24 | $58.4M | $42.2M | ||
| Q2 24 | $-66.1M | $9.5M | ||
| Q1 24 | $63.9M | $-1.4M |
| Q4 25 | — | $148.6M | ||
| Q3 25 | $77.4M | $29.8M | ||
| Q2 25 | — | $56.7M | ||
| Q1 25 | $-119.1M | $-90.0M | ||
| Q4 24 | $307.2M | $274.9M | ||
| Q3 24 | $7.4M | $15.1M | ||
| Q2 24 | $-122.8M | $-18.9M | ||
| Q1 24 | $11.7M | $-26.5M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | 5.8% | 2.9% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | -9.6% | -8.6% | ||
| Q4 24 | 24.3% | 24.2% | ||
| Q3 24 | 0.6% | 1.4% | ||
| Q2 24 | -9.8% | -1.8% | ||
| Q1 24 | 0.9% | -2.4% |
| Q4 25 | 3.5% | 2.4% | ||
| Q3 25 | 3.3% | 2.1% | ||
| Q2 25 | 4.0% | 1.8% | ||
| Q1 25 | 4.7% | 2.4% | ||
| Q4 24 | 5.0% | 3.3% | ||
| Q3 24 | 4.1% | 2.5% | ||
| Q2 24 | 4.5% | 2.7% | ||
| Q1 24 | 4.2% | 2.3% |
| Q4 25 | — | — | ||
| Q3 25 | 3.36× | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | -1.17× | — | ||
| Q4 24 | 9.61× | — | ||
| Q3 24 | 2.02× | — | ||
| Q2 24 | -1.43× | — | ||
| Q1 24 | 1.30× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCO
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
